HomeCompareEMC vs JNJ

EMC vs JNJ: Dividend Comparison 2026

EMC yields 0.78% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMC wins by $757.00 in total portfolio value
10 years
EMC
EMC
● Live price
0.78%
Share price
$30.81
Annual div
$0.24
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$82.32
Full EMC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EMC vs JNJ

📍 EMC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMC
Annual income on $10K today (after 15% tax)
$66.50/yr
After 10yr DRIP, annual income (after tax)
$69.97/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $633.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMC + JNJ for your $10,000?

EMC: 50%JNJ: 50%
100% JNJ50/50100% EMC
Portfolio after 10yr
$20.4K
Annual income
$455.05/yr
Blended yield
2.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EMC
No analyst data
Altman Z
1.6
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMC buys
5
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$EMC▲ Buy$15,001 - $50,0002023-06-22
Ro Khanna🏢 House$EMC▲ Buy$1,001 - $15,0002023-04-20
Angus King🏛 Senate$EMC▼ Sell$1,001 - $15,0002016-07-14
Angus King🏛 Senate$EMC▼ Sell$1,001 - $15,0002016-07-14
Susan M. Collins🏛 Senate$EMC▼ Sell$1,001 - $15,0002016-02-09
Susan M. Collins🏛 Senate$EMC▼ Sell$1,001 - $15,0002016-02-09
Susan M. Collins🏛 Senate$EMC▼ Sell$1,001 - $15,0002016-02-09
John Reed🏛 Senate$EMC▼ Sell$1,001 - $15,0002015-04-23
Susan M. Collins🏛 Senate$EMC▲ Buy$1,001 - $15,0002014-07-23
Susan M. Collins🏛 Senate$EMC▲ Buy$1,001 - $15,0002014-07-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMCJNJ
Forward yield0.78%3.36%
Annual dividend / share$0.24$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.8K$20.0K
Annual income after 10y$82.32$827.78
Total dividends collected$804.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMC vs JNJ ($10,000, DRIP)

YearEMC PortfolioEMC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,778$78.24$10,676$355.77+$102.00EMC
2$11,612$78.81$11,407$389.39+$205.00EMC
3$12,504$79.35$12,198$426.53+$306.00EMC
4$13,459$79.85$13,056$467.62+$403.00EMC
5$14,481$80.33$13,987$513.12+$494.00EMC
6$15,576$80.78$14,998$563.56+$578.00EMC
7$16,747$81.20$16,098$619.52+$649.00EMC
8$18,001$81.60$17,295$681.69+$706.00EMC
9$19,343$81.97$18,599$750.82+$744.00EMC
10$20,779$82.32$20,022$827.78+$757.00EMC

EMC vs JNJ: Complete Analysis 2026

EMCStock

The Global X Emerging Markets Great Consumer ETF (EMC) seeks to achieve long-term capital growth.

Full EMC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EMC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMC vs SCHDEMC vs JEPIEMC vs OEMC vs KOEMC vs MAINEMC vs ABBVEMC vs MRKEMC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.